Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy

BACKGROUND: India has more than 5.7 million people infected with human immunodeficiency virus (HIV). In 2004, the Indian government began providing antiretroviral therapy (ART), and there are now an estimated 56 500 people receiving ART. OBJECTIVE: To project the life expectancy, cost, and cost-effe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Freedberg, Kenneth A., Kumarasamy, Nagalingeswaran, Losina, Elena, Cecelia, Anitha J., Scott, Callie A., Divi, Nomita, Flanigan, Timothy P., Lu, Zhigang, Weinstein, Milton C., Wang, Bingxia, Ganesh, Aylur K., Bender, Melissa A., Mayer, Kenneth H., Walensky, Rochelle P.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2365748/
https://ncbi.nlm.nih.gov/pubmed/17620747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.aids.0000279714.60935.a2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares